Partager

Best Practices / Guidelines


  • 16-October-2020

    English

    Digital Economy, Innovation and Competition

    The increasing prominence of the digital economy has been requiring competition authorities to devote more and more of their time to intellectual property-intensive and high technology industries. Digital Economy has became one of the OECD Competition Committee's areas of study for the next years to come.

    Related Documents
  • 15-October-2020

    English

    Best Practice Roundtables on Competition Policy

    Each year, the Competition Committee holds several Best Practice Roundtables. This list contains links to the proceedings from these roundtables from 1995 to the present date.

    Related Documents
  • 1-October-2020

    English

    Gender inclusive competition policy

    The fight for gender equality is one of the defining challenges of our age. While progress has been made in many areas, the relationship between gender and competition policy remains largely unexplored. Gender inclusive competition policy is a project with the support of the Canadian government that aims to develop guidance for competition agencies in this area.

    Related Documents
  • 15-September-2020

    English

    Competition Assessment Toolkit

    The Toolkit helps governments to eliminate barriers to competition by providing a method for identifying unnecessary restraints on market activities and developing alternative, less restrictive measures that still achieve government policy objectives.

    Related Documents
  • 30-April-2020

    English, PDF, 332kb

    COVID-19: Competition policy actions for governments and competition authorities

    This policy note outlines actions that governments and competition authorities can consider to help address the immediate challenges raised by the crisis whilst looking to the post-pandemic future.

    Related Documents
  • 30-April-2020

    English, PDF, 391kb

    COVID-19: Competition and emergency procurement

    This notes examines the conditions when direct awards may be necessary for emergency reasons and provides guidance for procurement and competition authorities for when departing from competitive tenders may be justified.

    Related Documents
  • 30-April-2020

    English, PDF, 344kb

    COVID-19: Managing operational challenges and enforcement risks for competition authorities

    This note looks at the operational challenges and enforcement risks for competition authorities arising from the crisis and the confinement measures and provides some guidance to authorities.

    Related Documents
  • 4-décembre-2019

    Français

    Obstacles à la sortie dans la concurrence

    En décembre 2019, l'OCDE a tenu une table ronde pour discuter de ce que sont les barrières à la sortie; quel est leur impact sur l'allocation efficace, et quel est leur impact sur la concurrence. Il a été discuté de la manière dont les autorités considèrent les barrières à la sortie dans leur travail de mise en application, et les cas où les barrières à la sortie ont été une considération importante.

    Documents connexes
    Also AvailableEgalement disponible(s)
  • 2-juillet-2019

    Français

    Recommandation du Conseil concernant une action efficace contre les ententes injustifiables

    Le 2 juillet 2019 le Conseil a adopté la Recommandation concernant une action efficace contre les ententes injustifiables qui intégre les avancées intervenues dans les régimes de lutte contre les ententes qui se sont produites au cours des 20 dernières années, y compris les programmes de clémence, les outils et pouvoirs d’enquête proactifs, les procédures amiables, les sanctions effectives et les actions privées d'indeminisation.

    Documents connexes
  • 28-November-2018

    English

    Excessive Pricing in Pharmaceuticals

    A number of competition enforcement actions against excessive pricing have taken place in the pharmaceutical sector, despite competition authorities usually being reluctant to intervene directly against high prices. In November 2018, the OECD held a discussion on the intersection of competition concerns with excessive prices and the interaction between competition and regulated sectors such as pharma.

    Related Documents
  • 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>